Phase 3 to NDA - 57%
NDA to approval - 81%
0.57 x 0.81 = 46% overall
I took that from pages 11 and 12 of that document.
I'm not saying for a moment that is NEU's chances. That is the industry average for neurology drugs.
Phase 3 to NDA - 57% NDA to approval - 81% 0.57 x 0.81 = 46%...
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.34 |
Change
-0.315(2.31%) |
Mkt cap ! $1.719B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.24 | $1.549M | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 73 | $13.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.36 | 470 | 6 |
View Market Depth
| Last trade - 12.40pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |